First Line Treatment With Olaparib in Combination With Bevacizumab in HRD Positive Patients

Olaparib is considered the study treatment. Olaparib tablets will be taken at the dose of 300 mg (2 x 150 mg tablet) twice daily adding to bevacizumab at a dose of 15 mg per kilogram of body weight every 3 weeks

Bevacizumab will be taken at a dose of 15 mg per kilogram of body weight every 3 weeks